GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medipost Co Ltd (XKRX:078160) » Definitions » Price-to-Funds-From-Operations

Medipost Co (XKRX:078160) Price-to-Funds-From-Operations : (As of Apr. 30, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Medipost Co Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Medipost Co (XKRX:078160) Business Description

Industry
Traded in Other Exchanges
N/A
Address
21, Daewangpangyo-ro 644, Bundang-gu, Gyeonggi-do, Seongnam, KOR
Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.